We are pleased to announce the release of Xpression, an integrated RNA-seq analysis pipeline.
Xpression automatically processes quality filtering, mapping, expression profiling, and visualization from short read-length NGS reads in nucleotide-space (e.g., Illumina). It currently uses BWA to map reads, which allows a specified number of mismatches between read and reference genome. The expression profile provides normalization for reads per million (pM) and per million-kilobase (pKM). It can also take read orientation of the reads into account if strand-specificity was maintained during the library-prep method.
This pipeline can be run on UNIX-like systems via the command-line or graphically via Java. To run Xpression on any system, such as Windows, a fully-configured virtualized environment is also provided. This environment needs software such as VirtualBox to run, which can be downloaded and installed with a standard point-and-click wizard interface.
The Integrative Genomics Viewer (Broad) is recommended for viewing the wiggle-format visualization files, and we have found Tablet to be a good choice for viewing the sorted bam files.
The project website:
The code's home (including the issue tracker and source):
Additionally, the design of the tool allows flexible use and easy modification to suit specific needs.
If you find our software useful, please use the following citation:
Phattarasukol S, Radey M, Lappala C, Oda Y, Hirakawa H, Brittnacher M, and Harwood CS. 2012. Identification of a p-coumarate degradation regulon in Rhodopseudomonas palustris using Xpression, an integrated tool for prokaryotic RNA-seq data processing. Appl. Environ. Microbiol. In press.
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...